SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-089720
Filing Date
2022-03-30
Accepted
2022-03-30 15:51:52
Documents
2
Group Members
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.VIFOR PHARMA LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d260205dsc13g.htm SC 13G 86047
2 EX-99.A d260205dex99a.htm EX-99.A 972
  Complete submission text file 0001193125-22-089720.txt   88562
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93548 | Film No.: 22786283
SIC: 2834 Pharmaceutical Preparations

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Filed by) CIK: 0001675217 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G